Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Gains from Sales and Divestitures (2016 - 2017)

Ocugen's Gains from Sales and Divestitures history spans 3 years, with the latest figure at $1889.0 for Q4 2017.

  • For Q4 2017, Gains from Sales and Divestitures fell 42.77% year-over-year to $1889.0; the TTM value through Dec 2017 reached $1889.0, down 42.77%, while the annual FY2017 figure was $1889.0, 42.77% down from the prior year.
  • Gains from Sales and Divestitures reached $1889.0 in Q4 2017 per OCGN's latest filing, roughly flat from $1889.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $3303.0 in Q4 2015 to a low of $1889.0 in Q2 2015.
  • Average Gains from Sales and Divestitures over 3 years is $2203.0, with a median of $1889.0 recorded in 2015.
  • Peak YoY movement for Gains from Sales and Divestitures: changed 0.0% in 2016, then tumbled 42.77% in 2017.
  • A 3-year view of Gains from Sales and Divestitures shows it stood at $3303.0 in 2015, then decreased by 0.06% to $3301.0 in 2016, then plummeted by 42.77% to $1889.0 in 2017.
  • Per Business Quant, the three most recent readings for OCGN's Gains from Sales and Divestitures are $1889.0 (Q4 2017), $1889.0 (Q3 2017), and $1889.0 (Q2 2017).